 Since 2006, many countries have implemented publicly funded human papillomavirus immunization programs. Global estimates of the extent and impact of vaccine coverage are still unavailable. 47 million women, 95 percent C.I. 39 to 55 million, received the full course of vaccine, representing a total population coverage of 1 times 4 percent. In more developed regions, 33 times 6 percent of females aged 10 to 20 years received full vaccine, compared with only 2 times 7 percent in less developed regions. This article was offered by Dr. Lya Bruni, M.D., M.E.I.A.D. as, P.H.D., Leslie Bionueva-Roses, M.D., and others.